Variant t(11;22)(q13;q11.2) with IGL involvement in mantle cell lymphoma.

Click to increase image sizeClick to decrease image size Disclosure statementThe following represents disclosure information provided by the authors of this manuscript. BTV has received honoraria from Janssen, Novartis and Bristol Myers Squibb. AMN has received honoraria from Lilly, Kite, AstraZeneca, AbbVie, BeiGene, Janssen, Takeda, and Kiowa Kirin. SB has received honoraria from Gilead and Roche. FB has received honoraria from Janssen, Karyospharm, Mundipharma, BeiGene, Gilead, Roche, AbbVie, Celgene/BMS, AstraZeneca, Novartis, Lilly and Takeda. All remaining authors have no conflicts to declare.